Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Type b”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Large-scale testing (Phase 3)Study completedNCT00678301
What this trial is testing

Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 365
Large-scale testing (Phase 3)Study completedNCT00514709
What this trial is testing

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,843
Large-scale testing (Phase 3)Study completedNCT01019772
What this trial is testing

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 217
Testing effectiveness (Phase 2)Study completedNCT00289185
What this trial is testing

Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 340
Testing effectiveness (Phase 2)Study completedNCT00135564
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Post-approval studies (Phase 4)Study completedNCT04535037
What this trial is testing

Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

Who this might be right for
Diphtheria
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT00814710
What this trial is testing

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 360
Large-scale testing (Phase 3)Study completedNCT00496015
What this trial is testing

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 750
Post-approval studies (Phase 4)Not Yet RecruitingNCT06748612
What this trial is testing

Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

Who this might be right for
Polio
International Centre for Diarrhoeal Disease Research, Bangladesh 1,190
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Large-scale testing (Phase 3)UnknownNCT02560272
What this trial is testing

Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried

Who this might be right for
Haemophilus Influenzae Type b Infections
Beijing Minhai Biotechnology Co., Ltd 1,560
Testing effectiveness (Phase 2)Study completedNCT00134719
What this trial is testing

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 1,104
Large-scale testing (Phase 3)Study completedNCT00609492
What this trial is testing

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
GlaxoSmithKline 245
Large-scale testing (Phase 3)Study completedNCT01337167
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 1,473
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Testing effectiveness (Phase 2)Study completedNCT00831311
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 624
Large-scale testing (Phase 3)Study completedNCT01457508
What this trial is testing

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more
GlaxoSmithKline 440
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Early research (Phase 1)Study completedNCT05401305
What this trial is testing

Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

Who this might be right for
Haemophilus Influenzae InfectionVaccines
St. Petersburg Research Institute of Vaccines and Sera 60
Load More Results